Bristol Myers Squibb Stock Falls on Report of $400 Billion Merger Talks With AstraZeneca - Barron's
Source:Barron's
A merger between Bristol Myers Squibb and AstraZeneca would be one of the biggest pharma deals ever. AstraZeneca’s market capitalization stood at $264 billion as of Friday’s close, while Bristol Myers Squibb had a total valuation of $133 billion.